We observed that when compared to the primary cancer specimens, KRT13 staining was more intense in all three human cancer bone metastatic specimens, and KRT13 staining was also more intense in breast and lung cancer brain metastatic specimens compared to the primary breast and lung cancer tissue specimens. This evidence concerns the gene KRT13 and cancer.